From: Mortality risk in patients with autosomal dominant polycystic kidney disease
Non-ESRD CKD | ESRD | ||||||
---|---|---|---|---|---|---|---|
Characteristic | Category | Adjusted HR (95% CI) | P value | Characteristic | Category | Adjusted HR (95% CI) | P value |
Stage | Stage 1 | 0.28 (0.04–2.01) | 0.2058 | Treatment | Dialysis | 1.92 (1.78–2.07) | < 0.0001 |
Stage 2 | 0.71 (0.35–1.47) | 0.3588 | Transplant | Reference | N/A | ||
Stage 3 | Reference | N/A | |||||
Stage 4 | 1.60 (1.12–2.29) | 0.0096 | |||||
Stage 5 | 1.85 (0.75–4.60) | 0.1837 | |||||
Age group | 65–74 years | Reference | N/A | Age group | 65–74 years | Reference | N/A |
75–84 years | 1.70 (1.13–2.55) | 0.0108 | 75–84 years | 1.83 (1.69–1.98) | < 0.0001 | ||
85 years and older | 3.43 (2.27–5.19) | < 0.0001 | 85 years and older | 3.04 (2.67–3.46) | < 0.0001 | ||
Sex | Female | 0.77 (0.55–1.07) | 0.1178 | Sex | Female | 0.93 (0.87–1.00) | 0.0419 |
Male | Reference | N/A | Male | Reference | N/A | ||
Race | Black | 1.41 (0.90–2.21) | 0.1377 | Race | Black | 0.87 (0.77–0.97) | 0.0150 |
Hispanic | 1.22 (0.30–4.93) | 0.7847 | Hispanic | 0.69 (0.60–0.80) | < 0.0001 | ||
Asian | 1.48 (0.60–3.65) | 0.3925 | Asian | 0.71 (0.57–0.89) | 0.0025 | ||
Other or unknown a | 0.53 (0.13–2.14) | 0.3709 | Other or unknown a | 0.77 (0.51–1.17) | 0.2228 | ||
White | Reference | N/A | White | Reference | N/A |